Efficacy of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with ADHD: head-to-head responder analyses

被引：0
|
作者：
Cardo, E. [1 ,2 ]
Coghill, D. [3 ]
Nagy, P. [4 ]
Adeyi, B. [5 ]
Anderson, C. [6 ]
Caballero, B. [7 ]
Higgins, N. [8 ]
Hodgkins, P. [9 ]
Civil, R. [10 ]
Dittmann, R. W. [11 ]
机构：
[1] Univ Balearic Isl, Son Llatzer Hosp, Palma De Mallorca, Spain
[2] Res Inst Hlth Sci, Palma De Mallorca, Spain
[3] Univ Dundee, Div Neurosci, Dundee, Scotland
[4] Vadaskert Child & Adolescent Psychiat Hosp, Outpatient Clin, Budapest, Hungary
[5] Shire Dev LLC, Global Biostat, Wayne, NJ USA
[6] Shire Dev LLC, Global Clin Programs, Wayne, NJ USA
[7] Shire AG, Clin Dev & Med Affairs, Eysins, Switzerland
[8] Shire Dev LLC, Clin Programs, Wayne, NJ USA
[9] Shire Dev LLC, Global Hlth Econ & Outcomes Res, Wayne, NJ USA
[10] Shire Dev LLC, Clin Dev & Med Affairs, Wayne, NJ USA
[11] Heidelberg Univ, Dept Child & Adolescent Psychiat & Psychotherapy, Mannheim, Germany
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2013年 / 23卷
关键词：
D O I：
10.1016/S0924-977X(13)70960-X
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.7.d.008
引用
收藏
页码：S603 / S604
页数：2
相关论文
共 50 条
  • [1] Evaluation of a head-to-head study of lisdexamfetamine dimesylate and atomoxetine
    Banaschewski, Tobias
    Rothermel, Boris
    Poustka, Luise
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (13) : 1961 - 1965
  • [2] Treatment Response and Remission in a Double-Blind, Randomized, Head-to-Head Study of Lisdexamfetamine Dimesylate and Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity Disorder
    Ralf W. Dittmann
    Esther Cardo
    Peter Nagy
    Colleen S. Anderson
    Ben Adeyi
    Beatriz Caballero
    Paul Hodgkins
    Richard Civil
    David R. Coghill
    CNS Drugs, 2014, 28 : 1059 - 1069
  • [3] Treatment Response and Remission in a Double-Blind, Randomized, Head-to-Head Study of Lisdexamfetamine Dimesylate and Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity Disorder
    Dittmann, Ralf W.
    Cardo, Esther
    Nagy, Peter
    Anderson, Colleen S.
    Adeyi, Ben
    Caballero, Beatriz
    Hodgkins, Paul
    Civil, Richard
    Coghill, David R.
    CNS DRUGS, 2014, 28 (11) : 1059 - 1069
  • [4] A head-to-head, double-blind, randomized, phase 3b trial comparing the efficacy of lisdexamfetamine dimesylate with atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder
    Dittmann, Ralf
    Cardo, Esther
    Coghill, David
    Nagy, Peter
    Adeyi, Ben
    Anderson, Colleen
    Caballero, Beatriz
    Higgins, Nicholas
    Hodgkins, Paul
    Civil, Richard
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2013, 22 : S222 - S223
  • [5] Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate
    Peter Nagy
    Alexander Häge
    David R. Coghill
    Beatriz Caballero
    Ben Adeyi
    Colleen S. Anderson
    Vanja Sikirica
    Esther Cardo
    European Child & Adolescent Psychiatry, 2016, 25 : 141 - 149
  • [6] Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with ADHD: randomised withdrawal design
    Coghill, D.
    Banaschewski, T.
    Lecendreux, M.
    Johnson, M.
    Zuddas, A.
    Anderson, C.
    Civil, R.
    Lyne, A.
    Gasior, M.
    Squires, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S431 - S432
  • [7] Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: a Head-to-Head, Randomized, Double-Blind, Phase IIIb Study
    Ralf W. Dittmann
    Esther Cardo
    Peter Nagy
    Colleen S. Anderson
    Ralph Bloomfield
    Beatriz Caballero
    Nicholas Higgins
    Paul Hodgkins
    Andrew Lyne
    Richard Civil
    David Coghill
    CNS Drugs, 2013, 27 : 1081 - 1092
  • [8] Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: a Head-to-Head, Randomized, Double-Blind, Phase IIIb Study
    Dittmann, Ralf W.
    Cardo, Esther
    Nagy, Peter
    Anderson, Colleen S.
    Bloomfield, Ralph
    Caballero, Beatriz
    Higgins, Nicholas
    Hodgkins, Paul
    Lyne, Andrew
    Civil, Richard
    Coghill, David
    CNS DRUGS, 2013, 27 (12) : 1081 - 1092
  • [9] Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate
    Nagy, Peter
    Haege, Alexander
    Coghill, David R.
    Caballero, Beatriz
    Adeyi, Ben
    Anderson, Colleen S.
    Sikirica, Vanja
    Cardo, Esther
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2016, 25 (02) : 141 - 149
  • [10] Clinical efficacy of lisdexamfetamine dimesylate in children and adolescents with ADHD: a post-hoc analysis
    Zuddas, A.
    Banaschewski, T.
    Lecendreux, M.
    Soutullo, C.
    Johnson, M.
    Anderson, C.
    Civil, R.
    Bloomfield, R.
    Squires, L.
    Coghill, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S431 - S431
12345